O126 Repeat hepatic resection for recurrent colorectal metastasis

Abstract Introduction Liver resection offers the best curative treatment for hepatic metastases secondary to colorectal (CR) cancer. The aim of this study was compare survival outcomes between patients having liver once (OR) versus those redo-liver (RR) metastases. Methods This a retrospective done on 171 who underwent (97 had OR & 74 RR) from January 2009 2020 across East Midlands hospitals. Results Mean age in group 75 years RR 74. Male: female ratio 2:1 and 1.34:1 group. period first second around 15.4 months. Minimum follow up after surgery 3 years. Up point till Jan.2023, overall there were 58 deaths reported out total 97 group, while 39 patients. At initial resection, 58% 65%. 5 up, 40% that 45%. It also noted 67% (1/3) lymph node positive disease (≥N1). Conclusion Beneficial outcome has been with regards undergoing redo supports its role as preferred choice management recurrent metastasis.